Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
5.16
-0.06 (-1.15%)
At close: Jan 2, 2026, 4:00 PM EST
5.19
+0.03 (0.57%)
Pre-market: Jan 5, 2026, 8:00 AM EST
Radiopharm Theranostics Employees
Radiopharm Theranostics had 14 employees as of June 30, 2025.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
$585,935
Profits / Employee
-$1,795,546
Market Cap
59.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RADX News
- 20 days ago - Why Is Radiopharm Theranostics Stock Rallying Over 140%? - Benzinga
- 21 days ago - Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases - GlobeNewsWire
- 2 months ago - Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan - GlobeNewsWire
- 4 months ago - Radiopharm Theranostics Limited - Special Call - Seeking Alpha
- 5 months ago - Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update - GlobeNewsWire
- 5 months ago - Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board - GlobeNewsWire
- 7 months ago - Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake - GlobeNewsWire
- 8 months ago - ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - GlobeNewsWire